Jennifer Chien
Corporate Officer/Principal chez RHYTHM PHARMACEUTICALS, INC.
Fortune : 261 404 $ au 30/04/2024
Postes actifs de Jennifer Chien
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/11/2020 | - |
Historique de carrière de Jennifer Chien
Anciens postes connus de Jennifer Chien
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 20/01/2020 | 16/10/2020 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/11/2014 | 01/01/2020 |
Formation de Jennifer Chien
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Jennifer Chien
- Expérience
